Comparative quantitative systems pharmacology modeling of anti-PCSK9 therapeutic modalities in hypercholesterolemia

Since the discovery of proprotein convertase subtilisin/kexin type 9 (PCSK9) as an attractive target in the treatment of hypercholesterolemia, multiple anti-PCSK9 therapeutic modalities have been pursued in drug development. The objective of this research is to set the stage for the quantitative ben...

Descripción completa

Detalles Bibliográficos
Autores principales: Sokolov, Victor, Helmlinger, Gabriel, Nilsson, Catarina, Zhudenkov, Kirill, Skrtic, Stanko, Hamrén, Bengt, Peskov, Kirill, Hurt-Camejo, Eva, Jansson-Löfmark, Rasmus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society for Biochemistry and Molecular Biology 2019
Materias:
Patient-Oriented and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718444/
https://www.ncbi.nlm.nih.gov/pubmed/31292220
http://dx.doi.org/10.1194/jlr.M092486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6718444/
https://www.ncbi.nlm.nih.gov/pubmed/31292220
http://dx.doi.org/10.1194/jlr.M092486

Ejemplares similares